Fengqiang Zhou
Papers
1
Total Citations
4
H-Index
1
About
Fengqiang Zhou is a leading clinical researcher in gastrointestinal oncology, with a primary focus on optimizing surgical outcomes for gastric cancer patients through perioperative interventions. His most cited work centers on the innovative use of probiotic supplements to improve short-term clinical outcomes following laparoscopic or robotic radical gastrectomy, particularly in patients who have undergone neoadjuvant chemotherapy. This multicenter randomized controlled trial protocol (GISSG2023-01 Study) addresses a critical gap in managing advanced gastric cancer, where neoadjuvant chemotherapy is standard but often compromises gut health and recovery. Zhou’s research bridges oncology and surgical care, exploring how microbiome modulation can reduce complications and enhance postoperative recovery. With 4 citations to this key protocol, his work is gaining traction among surgeons and oncologists seeking evidence-based strategies to improve patient outcomes. By targeting the intersection of chemotherapy, surgery, and gut health, Zhou is advancing personalized perioperative care for one of the most challenging malignancies, positioning himself as a rising voice in translational surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1